Skip to main content

SSRIs for Hot Flashes
vs
Vaginal Dryness Pills

A side-by-side comparison of two menopause relief methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
SSRIs for Hot Flashes

SSRIs for Hot Flashes

A low-dose SSRI (paroxetine 7.5 mg) approved by the FDA for moderate-to-severe hot flashes.

Vaginal Dryness Pills

Vaginal Dryness Pills

SERM prescription pills that act like estrogen in some tissues and block it in others to relieve vaginal dryness and painful sex.

EfficacyRecommended see details

Recommended by the Menopause Society for symptom relief.

68.3% had symptom improvement

Around 68% had symptom improvement.

Cost$0–$200 /monthly

Insurance: Usually

$0–$340 /monthly

Insurance: Usually

DurationDaily pill (ongoing)Daily pill (ongoing)
ReversibilityReversibleReversible
STI ProtectionNoNo
How it works

Low-dose paroxetine affects serotonin and other neurotransmitters involved in temperature regulation, which can reduce hot flash frequency and severity.

SERMs bind to estrogen receptors and act like estrogen in some tissues (bone, vagina) while blocking estrogen in others (breast, uterus). This tissue-selective action can treat menopause symptoms without systemic estrogen.

PrescriptionRequired Prescription requiredRequired Prescription required
Available Products1 product1 product
Side effects
  • Nausea
  • Headache
  • Fatigue or malaise
  • Hot flashes (paradoxical in some users)
  • Vaginal discharge
  • Muscle spasms
  • Hyperhidrosis
  • Headache
  • Vaginal hemorrhage
  • Night sweats
Who shouldn't use this
  • Current or recent MAOI use (within 14 days)
  • Concomitant thioridazine or pimozide
  • Pregnancy
  • Hypersensitivity to paroxetine or any ingredient
  • Known or suspected estrogen-dependent neoplasia (e.g., breast or endometrial cancer)
  • Active DVT, pulmonary embolism, or a history of these conditions
  • Active arterial thromboembolic disease (e.g., stroke, myocardial infarction) or a history of these conditions
  • Undiagnosed abnormal genital bleeding
  • Known or suspected pregnancy
  • Hypersensitivity to ospemifene or any ingredient